Get More Information on Precision Diagnostics Market - Request Sample Report
The Precision Diagnostics Market Size was valued at USD 75.87 Billion in 2023, and is expected to reach USD 224.53 Billion by 2032, and grow at a CAGR of 13.50%.
The most crucial driver of market growth is advancements in genomic and proteomic sciences. The continued research and development in precision diagnostics have led to the integration of new technologies with improved precision rates. Besides, there is a growing prevalence of chronic diseases across the globe, and early detection can enhance the quality of life for the affected individuals. As such, healthcare professionals currently rely on precision diagnostics to develop personalized treatment plans for various conditions. Regarding tests and platforms, there have been various developments that have integrated AI and machine learning algorithms to enhance their precision and speed of operation. On the part of healthcare professionals and patients, there is a growing awareness and acceptance of precision diagnostics approaches and technologies. Therefore, the factors above have been beneficial in supporting the growth and expansion of the market. It is significant to note that the driver with the most significant potential is the government investment as it creates avenues for integrating precision diagnostics in public health systems.
Another key driver of the market is the increasing aging population and the subsequent market demand. The World Health Organization reports that by the year 2050, the global population aged 60 years and above will double to 2.1 billion. Additionally, the population of people aged 80 years and older will increase by three times to about 426 million individuals. As people grow older, it becomes inevitable to contract various diseases and health conditions, which have to be diagnosed early to develop a suitable treatment plan. The tests for the conditions in question fall under precision diagnostics and include testing technologies such as genetic and molecular tests and advanced analytical tools such as big data computing to provide personalized and precise diagnostic information. Consequently, older adults provide a critical driver of the global market because of increased demand for advanced diagnostic solutions to manage old age diseases more effectively. It is important to note that the inclusion of other factors that can drive the global market expansion can be explored in case the report is for an African market.
Key Drivers:
The Development of Advanced Diagnostic Techniques, Such as Next-Generation Sequencing and Liquid Biopsy, is Driving the Growth of the Precision Diagnostics Market.
The Rising Incidence of Chronic Diseases, Such as Cancer and Autoimmune Disorders, is Increasing the Demand for Precision Diagnostic Tests to Identify and Treat These Conditions Effectively.
Restraints:
Precision Diagnostic Tests Can Be Expensive, Which May Limit Their Accessibility to Patients and Healthcare Providers.
Obtaining Regulatory Approval for New Precision Diagnostic Tests Can Be Time-Consuming and Costly, Which May Hinder Market Entry.
Opportunity:
There is a Growing Trend Towards Personalized Medicine, Which Relies on Precision Diagnostics to Tailor Treatment Plans to Individual Patients.
Precision Diagnostics is Being Applied to A Wider Range of Diseases, Including Infectious Diseases and Rare Genetic Disorders, Which Presents New Opportunities for Market Growth.
The genetic tests segment led the market. It accounted for 55% of the share in 2023. The dominance of genetic tests in the market is attributed to various factors such as advancements in technology, improved understanding of genetic disorders, the advent of personalized medicine, increasing prevalence of chronic diseases and cancer, consumer curiosity to understand more about their ancestry, and regulatory support. The sector has also observed numerous investments and partnerships between diagnostic, pharmaceutical companies, and academic institutions. These collaborations are focused on developing new genetic tests and incorporating them into clinical applications to propel market growth. For example, in January 2024, DNAnexus, Inc. and TMA Precision Health announced a collaboration to support diagnostic processes and treatment options for individuals affected by rare diseases. The focus of the deal is on developing more accurate and effective tests that will help provide more personalized treatment plans for individuals with rare diseases.
The Direct to direct-to-consumer tests segment is expected to register the fastest CAGR from 2024 to 2032. Consumers are becoming increasingly aware of the importance of early disease detection and health information. DTC tests are a convenient method for individuals to access opportunities to improve their health and learn about potential concerns with their health without having to visit a healthcare provider. Moreover, advancements in genomic sequencing technologies as well as bioinformatics have made it easier and more cost-effective to launch such tests directly to the consumer. As a result, an increased variety of tests are available that possess greater accuracy ranging from genetic predispositions to lifestyle suggestions related to nutrition and exercise. In addition, regulatory bodies in some regions have begun to provide more concrete frameworks and guidelines concerning DTC genetic testing. This has benefitted firms by streamlining approval procedures, which has enabled them to launch products in the market.
The oncology segment was leading the market, based on application, with the largest revenue share of 25% in 2023. This is mainly attributed to the growing prevalence of cancer worldwide and the escalating need for early detection and monitoring of such diseases. According to the American Cancer Society, it is estimated that 1.96 million cases of cancer diagnosed in the U.S. alone in 2023. In this regard, such high prevalence is propelling the demand for personalized and more accurate diagnostics to target exact cancer types and know their genetic identities. In addition, the future expenditure of governments in this segment will enhance the growth of the market over the forecast period. For example, in the U.S., the National Cancer Institute has a budget allocation of USD 7.8 billion, and in the Fiscal Year 2023, there was a USD 500 million increment for personalized medicine.
The genetic disease application segment is estimated to be the fastest-growing segment over the forecast period. This is because of the surging prevalence of genetic disorders worldwide, which is fueling the demand for personalized diagnostic solutions. For example, among people of Caucasian origin, illness carriers are the highest, estimated at 16, which include Tay-Sachs among the Ashkenazi Jewish individuals, and one for Asians, including that for alpha- and beta-thalassemia. Therefore, since diseases such as cystic fibrosis, sickle cell anemia, and some types of cancer are genetic, cases of genetic disease are rising, hence the need for advanced diagnostics. The advent of next-generation sequencing and other high-throughput technologies has played a vital role in this sector. Therefore, these innovations can scrutinize and interpret copious amounts of genetic data swiftly and cost-effectively, thereby propelling the rapid growth of precision diagnostics to help in identifying genetic diseases.
In terms of revenue, North America was the leader of the Precision Diagnostics Market in 2023, with a 49% share, notably the U.S. The presence of advanced healthcare infrastructure and robust biotechnology research in the U.S. has ensured continuous investments in the field, which in turn has resulted in the development of more efficient and reliable personalized diagnostics technologies. Moreover, government measures to improve the quality and accessibility of healthcare as well as the continuous funding of research and development in the diagnostics field on the whole had a significant, positive effect on the market growth.
Moreover, the U.S. Precision Diagnostics Market is expected to demonstrate the highest CAGR in the following years. This trend can have several sources, including advances in the genomic medicine field and the growing understanding and awareness of personalized healthcare benefits. Another factor that influenced it was the increasing use of artificial intelligence in precision diagnostics and the steady and substantial market demand for earlier and more reliable detection of diseases. Furthermore, the sector is growing as a whole – while it is most often associated with genetic testing, precision diagnostics include such technologies as molecular diagnostics, companion diagnostics, and immunoassays. These technologies are employed to detect specific markers and connect various types of detecting equipment. Finally, the trend influences both the U.S. government and the private sector, and various programs and institutions have been supported in the country in the interest of developing the area. The most famous is the All of Us Research Program, which is considered to be a part of the Precision Medicine Initiative.
Need any customization research on Precision Diagnostics Market - Enquiry Now
The players operating in the precision diagnostics market are the following:
Illumina: NovaSeq, NextSeq, TruSight Tumor 170
Thermo Fisher Scientific: QuantStudio, Oncomine, Ion Torrent
Roche Diagnostics: cobas x 4800, Cobas 6800, Her2 test
Qiagen: QIAamp, QuantiGene, Neuromarkers
Agilent Technologies: SureSelect, SureTarget, SureSeq
Becton, Dickinson, and Company (BD): FACSCalibur, BD Oncura, BD VeriQuest
Abbott Laboratories: m2000, Alinity m, ID NOW
Siemens Healthineers: MAGNETOM, SOMATOM, Admera Health
Bio-Rad Laboratories: CFX96, S1000, ddPCR
Myriad Genetics: BRCA1/2 test, Hereditary Cancer Panel
Invitae Corporation: Genetic testing for hereditary diseases, carrier screening
Guardant Health: Guardant360, Guardant Omni
Foundation Medicine: FoundationOne CDx, FoundationOne Heme
Exact Sciences Corporation: Cologuard, Oncotype DX
Natera, Inc.: Panorama, Harmony, Mirabilite
Quest Diagnostics: Genetic testing for various conditions, newborn screening
LabCorp: Genetic testing for various conditions, newborn screening
Cepheid: GeneXpert System, Xpert MTB/RIF
Genomic Health: Oncotype DX, Oncotype DCIS Score
Adaptive Biotechnologies: Adaptive TCR, clonoSEQ
In January 2024, Siemens Healthineers and the Indian Institute of Science opened a joint laboratory for AI in Precision Medicine. The lab’s official name is Siemens Healthineers-Computational Data Sciences Collaborative Laboratory for AI in Precision Medicine. The laboratory focused on developing open-source AI tools for neurological diseases. It is critical for the development of AI for India, the primary focus of India being neurovascular diseases
In May 2023, HALO Precision Diagnostics, Inc. signed a partnership with Agamon Health. The partnership was intended to improve the quality of treatment and patient experience with HALO Precision Diagnostics.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 75.87 Billion |
| Market Size by 2032 | US$ 224.53 Billion |
| CAGR | CAGR of 13.50% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Type (Genetic Tests, Direct-to-Consumer Tests, Esoteric Tests, Others) •By Application (Oncology, Respiratory Diseases, Skin Diseases, CNS Disorders, Immunology, Genetic Diseases, Others) •By End-Use (Hospitals, Clinical Laboratories, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., bioMérieux SA, Becton, Dickinson and Company, Danaher Corporation, QIAGEN N.V., Hologic Inc., and Agilent Technologies Inc & other players |
| Key Drivers | •The Development of Advanced Diagnostic Techniques, Such as Next-Generation Sequencing and Liquid Biopsy, is Driving the Growth of the Precision Diagnostics Market. •The Rising Incidence of Chronic Diseases, Such as Cancer and Autoimmune Disorders, is Increasing the Demand for Precision Diagnostic Tests to Identify and Treat These Conditions Effectively. |
| RESTRAINTS | •Precision Diagnostic Tests Can Be Expensive, Which May Limit Their Accessibility to Patients and Healthcare Providers. •Obtaining Regulatory Approval for New Precision Diagnostic Tests Can Be Time-Consuming and Costly, Which May Hinder Market Entry. |
Ans: The Precision Diagnostics Market size was valued at US$ 75.87 billion in 2023.
Ans: The Precision Diagnostics Market is to grow at a CAGR of 13.50% over the forecast period 2024-2032.
Ans: Market is divided in three segments by Type, by Application and by End User.
Ans: APAC is said to be the region which will have the highest CAGR growth rate during the forecasted period because of the technological advancement in the healthcare industry in these regions.
Ans: Budget restrictions during a recession may cause cutting back on their investment in research and development (R&D).
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume: Device usage volume
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Type Benchmarking
6.3.1 Type specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Type launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Precision Diagnostics Market Segmentation, by Type
7.1 Chapter Overview
7.2 Genetic Tests
7.2.1 Genetic Tests Market Trends Analysis (2020-2032)
7.2.2 Genetic Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Direct-to-Consumer Tests
7.3.1 Direct-to-Consumer Tests Market Trends Analysis (2020-2032)
7.3.2 Direct-to-Consumer Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Esoteric Tests
7.4.1 Esoteric Tests Market Trends Analysis (2020-2032)
7.4.2 Esoteric Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Others
7.5.1 Others Market Trends Analysis (2020-2032)
7.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Precision Diagnostics Market Segmentation, by Application
8.1 Chapter Overview
8.2 Oncology
8.2.1 Oncology Market Trends Analysis (2020-2032)
8.2.2 Oncology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Respiratory Diseases
8.3.1 Respiratory Diseases Market Trends Analysis (2020-2032)
8.3.2 Respiratory Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Skin Diseases
8.4.1 Skin Diseases Market Trends Analysis (2020-2032)
8.4.2 Skin Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 CNS Disorders
8.5.1 CNS Disorders Market Trends Analysis (2020-2032)
8.5.2 CNS Disorders Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Immunology
8.6.1 Immunology Market Trends Analysis (2020-2032)
8.6.2 Immunology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.7 Genetic Diseases
8.7.1 Genetic Diseases Market Trends Analysis (2020-2032)
8.7.2 Genetic Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
8.8 Others
8.8.1 Others Market Trends Analysis (2020-2032)
8.8.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Precision Diagnostics Market Segmentation, by End-Use
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Clinical Laboratories
9.3.1 Clinical Laboratories Market Trends Analysis (2020-2032)
9.3.2 Clinical Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Others
9.4.1 Others Market Trends Analysis (2020-2032)
9.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Precision Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Precision Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Precision Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Precision Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Precision Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Precision Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Precision Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Precision Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Precision Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Precision Diagnostics Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
11. Company Profiles
11.1 Abbott Laboratories
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Type/ Services Offered
11.1.4 SWOT Analysis
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Type/ Services Offered
11.2.4 SWOT Analysis
11.3 Siemens Healthineers AG
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Type/ Services Offered
11.3.4 SWOT Analysis
11.4 Thermo Fisher Scientific Inc.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Type/ Services Offered
11.4.4 SWOT Analysis
11.5 bioMérieux SA
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Type/ Services Offered
11.5.4 SWOT Analysis
11.6 Becton, Dickinson and Company
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Type/ Services Offered
11.6.4 SWOT Analysis
11.7 Danaher Corporation
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Type/ Services Offered
11.7.4 SWOT Analysis
11.8 QIAGEN N.V.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Type/ Services Offered
11.8.4 SWOT Analysis
11.9 Hologic Inc.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Type/ Services Offered
11.9.4 SWOT Analysis
11.10 Agilent Technologies Inc.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Type/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Type
Genetic Tests
Direct-to-Consumer Tests
Esoteric Tests
Others
By Application
Oncology
Respiratory Diseases
Skin Diseases
CNS Disorders
Immunology
Genetic Diseases
Others
By End-Use
Hospitals
Clinical Laboratories
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Dental Practice Management Software Market Size was expected to reach USD 5.54 billion by 2031, and is valued at USD 2.55 billion in 2023, and grow at a CAGR of 10.2% over the forecast period 2024-2031.
The Biopharmaceutical CMO Market size was valued at USD 15.3 billion in 2023 and is expected to reach USD 58.2 billion by 2032 with a growing CAGR of 16% over the forecast period of 2024-2031.
The Healthcare Analytics Market was USD 43.05 billion by 2023 and growing at a CAGR of 21.2% from 2024 to 2031 and will reach USD 200.44 billion by 2031.
The 5G In Healthcare Market Size was valued at USD 25.2 billion in 2023 and will reach to USD 185.13 Bn by 2031, and grow at a CAGR of 28.31% by 2024-2031.
The Medication Management Market Size was valued at USD 7.08 Billion in 2023 and is expected to reach USD 13.37 Billion by 2032 and grow at a CAGR of 7.66% over the forecast period 2024-2032.
The Lab Automation Market size was estimated at USD 7.31 billion in 2023 and is expected to reach USD 13.05 billion by 2032, with a growing CAGR of 6.65% during the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
